Phase 2 Randomized, Noncomparative, Open-Label Study of Aflibercept and Modified Folfox6 in the First-Line Treatment of Metastatic Colorectal Cancer (Affirm)
Servizos
Servizos
Data de publicación
2012Título da revista
ANNALS OF ONCOLOGY
Tipo de contido
Publicación de congreso
